[SCHEDULE 13G/A] agilon health, inc. SEC Filing

Rhea-AI Filing Summary

Capital World Investors reports beneficial ownership of 10,852,943 shares of agilon health, representing 2.6% of the 414,423,149 shares outstanding. The filing states that Capital World Investors holds sole voting and dispositive power over those shares, and that the securities are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The disclosure is presented as an amendment to a prior Schedule 13G filing and identifies Capital World Investors as the reporting entity and an investment adviser organization.

Positive

• Clear disclosure of beneficial ownership and voting/dispositive powers
• Sole voting and dispositive power stated for the 10,852,943 shares, removing ambiguity about who controls votes for that stake
• Position characterized as passive and held in the ordinary course of business under Schedule 13G

Negative

• None.

Insights

Financial Analyst

TL;DR: A modest 2.6% passive stake with sole control of voting and disposition, disclosed via amended Schedule 13G.

Capital World Investors reports ownership of 10,852,943 shares, equal to 2.6% of the outstanding common stock. The position is characterized as passive under Schedule 13G with sole voting and dispositive power, indicating centralized execution of voting and trading decisions for that stake. For most investors, a sub-5% passive holding is routine and unlikely to alter corporate strategy, but the certified sole voting power means CWI will exercise its votes unilaterally on any matters presented to shareholders.

Corporate Governance Expert

TL;DR: Passive disclosure shows voting control for a non-controlling stake; governance impact is limited but direct.

The filing frames the position as held in the ordinary course of business and not intended to change control. Despite the non-controlling size (2.6%), the reporting of sole voting power is governance-relevant because CWI will cast votes independently on director elections and shareholder proposals. This does not indicate an active campaign for control, but it clarifies who will determine votes associated with this parcel of shares.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

agilon health, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

00857U107

(CUSIP Number)

08/29/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 00857U107

1

Names of Reporting Persons

Capital World Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 10,852,943.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,852,943.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,852,943.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.6 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: agilon health, Inc.
(b)	Address of issuer's principal executive offices: 440 Polaris Parkway, Ste 550, Westerville, OH 43082
Item 2.
(a)	Name of person filing: Capital World Investors
(b)	Address or principal business office or, if none, residence: 333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 00857U107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 10,852,943 ** **Capital World Investors ("CWI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 10,852,943 shares or 2.6% of the 414,423,149 shares believed to be outstanding.
(b)	Percent of class: 2.6 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 10,852,943
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 10,852,943
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital World Investors

Signature:	Timothy J. Moon
Name/Title:	Vice President and Senior Counsel, Capital Research and Management Company
Date:	09/05/2025

FAQ

How many agilon health (AGL) shares does Capital World Investors report owning?

Capital World Investors reports beneficial ownership of 10,852,943 shares of agilon health common stock.

What percentage of agilon health (AGL) does this stake represent?

The filing shows the stake represents 2.6% of the 414,423,149 shares believed to be outstanding.

Does Capital World Investors have voting control over these AGL shares?

Yes. The filing states Capital World Investors has sole voting power and sole dispositive power over the reported shares.

Is this filing indicating an attempt to influence control of agilon health (AGL)?

No. The certification states the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

What type of Schedule 13 filing is this for agilon health (AGL)?

The document is an amended Schedule 13G filing by Capital World Investors reporting a passive ownership position.